Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018050A1 Gamma three protease
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017837A1 Device at quantitative analysis of respiratory gases
03/06/2003WO2003017818A2 Management of gastro-intestinal disorders
03/06/2003WO2003017817A2 Diagnosis, prevention and treatment of cancer
03/06/2003WO2003017757A1 Rat with the onset of hereditary renal cancer and causative gene thereof
03/06/2003WO2003017755A2 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
03/06/2003WO2003000729A3 Secreted polypeptide and their use in the treatment of bone disorders
03/06/2003WO2002099822A3 Analytical device for test fluids, comprises a conductive polymer composition
03/06/2003WO2002099422A3 Individualization of therapy with alzheimer's disease agents
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002099078A3 Functional proteomic profiling
03/06/2003WO2002095359A3 Method and apparatus for detecting illicit substances
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086097A3 Methods for identifying the target of a compound which inhibits cellular proliferation
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination
03/06/2003WO2002081683A3 Protein analysis by means of immobilized arrays of antigens or antibodies
03/06/2003WO2002080647A3 Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples
03/06/2003WO2002075301A3 Diagnosis of pathogen infections using mass spectral analysis of immune system modulators in post-exposure biological samples.
03/06/2003WO2002074908A3 Methods and reagents for regulating apoptosis
03/06/2003WO2002074249A3 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002065134A3 Modulators of p53-p300 interactions and screening methods therefor
03/06/2003WO2002065128A3 Urine assay for ovarian reserve
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002064092A3 Method for evaluating therapeutic efficacy
03/06/2003WO2002063281A3 Optical gas sensor based on diffusion
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002059262A3 Compositions and methods for detecting proteolytic activity
03/06/2003WO2002057793A3 Method of detecting prp protein and kits therefor
03/06/2003WO2002056024A3 Detection methods
03/06/2003WO2002046761A8 Methods for detecting analytes using optical discs and optical disc readers
03/06/2003WO2002046721A8 Optical discs for measuring analytes
03/06/2003WO2002045835A3 Microelectronic arrays for cell-based functional genomics / high throughput phenotyping by electrokinetic assembly
03/06/2003WO2002043866A3 Apparatus and methods for separating components of particulate suspension
03/06/2003WO2002043561A3 Measuring haematocrit in blood vessels
03/06/2003WO2002042427A3 Mass tags for quantitative analysis
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002027027A3 Method of screening for therapeutics for infectious diseases
03/06/2003WO2002026947A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/06/2003WO2002024324A3 Focused acoustic energy in the preparation and screening of combinatorial libraries
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002020141A1 Device and method for separating undissolved constituents out of biological fluids
03/06/2003WO2002018636A3 Improvements in and relating to marking using dna
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002010710A9 Water monitoring system using bivalve mollusks
03/06/2003WO2002006522A3 Estrogen receptor gene polymorphisms as markers for determining a predisposition for low bone density
03/06/2003WO2002006478A8 Extracellular matrix protein
03/06/2003WO2002001228A8 Interaction of colloid-immobilized species with species on non-colloidal structures
03/06/2003WO2002000336A3 Composite arrays utilizing microspheres with a hybridization chamber
03/06/2003WO2001096540A3 Hepatitis c protease exosite for inhibitor design
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001083825A3 Colloid compositions for solid phase biomolecular analytical systems
03/06/2003WO2001073124A9 Rapid response glucose sensor
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003US20030046714 Anti-neovasculature preparations for cancer
03/06/2003US20030046011 Method for ab initio determination of macromolecular crystallographic phases at moderate resolution by a symmetry-enforced orthogonal multicenter spherical harmonic-spherical bessel expansion
03/06/2003US20030046010 Pattern discovery techniques for determining maximal irredundant and redundant motifs
03/06/2003US20030046008 Method and apparatus for automated alignment of flexible structures
03/06/2003US20030045827 Complexing of an ion, atom or molecule is prevented during the determination of the concentration by the addition or withdrawl of a substance
03/06/2003US20030045813 Blood gas syringe having improved blood barrier
03/06/2003US20030045746 Phosphorous organic compounds and their use
03/06/2003US20030045716 Detectable chemiluminescent acridinium ester label, comprising an acridinium ester with a hydrophilic modifier
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045694 Ultra-sensitive detection systems
03/06/2003US20030045693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045684 Polypeptide for use in humans therapeutics and diagnostics
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045529 Method for specifically potentiating N-type Ca2+ channel activity
03/06/2003US20030045491 Identification of cancerous cells and identifying antitumor drugs by detection of expression levels of tyrosine threonine kinase; inhibiting tumor growth (especially breast and colon cancer)by inhibiting activity of TTK
03/06/2003US20030045470 Methods and compositions for modulating gluconeogenesis using PGC-1
03/06/2003US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030045451 Determining or predicting response to cancer therapy in an individual using differential image analysis of immunohistochemically stained tumor samples.
03/06/2003US20030045005 Light-controlled electrokinetic assembly of particles near surfaces
03/06/2003US20030045004 Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL
03/06/2003US20030045003 Method for detection of the adulterant urine luckTM in urine using liquid chemistry, dry chemistry test pads, and lateral flow
03/06/2003US20030045002 Apparatus for use in the detection, absorption and analysis of preferential particles in sample
03/06/2003US20030045001 Apparatus for use in te detection of parasites in sample
03/06/2003US20030044998 Apparatus for use in the analysis and measurement of impurities in water
03/06/2003US20030044997 Biological material detection element, biological material detection method and apparatus, charged material moving apparatus
03/06/2003US20030044996 Detection of bacterial vaginosis
03/06/2003US20030044995 Reagent for detecting hemoglobin in blood sample
03/06/2003US20030044994 Detection and measurement of phosphorylation in a sample; insert sample into spectrophotometer, react sample with gas, detect and measure signal from phosphorus containing ion, determine the degree of phosphorylation
03/06/2003US20030044993 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
03/06/2003US20030044989 Apparatus and method for testing a beverage for a clandestine illicit substance
03/06/2003US20030044988 Hematology control product with increased closed vial stability
03/06/2003US20030044975 Cytokine-binding domain for use in the treatment of asthma and thrombocytopenia
03/06/2003US20030044973 Mammalian adrenocorticotropic hormone receptors and uses
03/06/2003US20030044970 Apparatus for use in monitoring tumor cell migaration
1 ... 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 ... 3937